choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Icagen Shares

Icagen Shares Newsletter
  • Icagen’s CEO and chief scientific officer receive raises 21 Nov 2018 16:40 GMT

    … Cunningham may purchase 535,000 shares of common stock, which … Krafte may purchase 120,000 shares of common stock, which also … XRPro Sciences Inc. before joining Icagen. In 2015, XPro Sciences … in 2003, Durham-based Icagen provides research and drug discovery …

  • $1.4 Billion Worldwide Compound Management Industry to 2030 - Outsourcing Services Segment to Maintain Fastest Growth 08 Feb 2023 23:17 GMT

    … Frontier Scientific, Inc. Hamilton Company Icagen Corporation Labcyte, Inc. TCG Lifesciences … and key competitor percentage market shares Market presence across multiple geographies …

  • Ligand Reports Third Quarter 2022 Financial Results 07 Nov 2022 21:11 GMT

    … Weighted average number of common shares-diluted   17,132     …   16,860       17,187   Add: Shares excluded due to anti-dilutive … weighted average number of common shares-diluted   17,132     … consideration related to Pfenex, Icagen, Crystal, CyDex, and …

  • Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement 16 Sep 2022 20:52 GMT

    … of approximately $60 million. Shares of the combined company … approximately 27.8 million shares of common stock and … prefunded warrants to purchase shares of common stock outstanding … including serving as Chairman of Icagen Inc., Chairman and Chief …

  • Ligand Reports Second Quarter 2022 Financial Results 08 Aug 2022 20:36 GMT

    … Weighted average number of common shares-diluted   16,868     …   16,846       17,210   Add: Shares excluded due to anti-dilutive … weighted average number of common shares-diluted   17,058     … consideration related to Pfenex, Icagen, Crystal, CyDex, and …

  • Ligand Reports First Quarter 2022 Financial Results 04 May 2022 20:17 GMT

    … Weighted average number of common shares-diluted   16,824     … weighted average number of common shares-diluted   17,193     … consideration related to Pfenex, Icagen, Crystal, CyDex, and … 796,071 potentially dilutive shares. View source version on …

  • Ligand Reports Fourth Quarter and Full Year 2021 Financial Results 17 Feb 2022 22:26 GMT

    … and eventual distribution of OmniAb shares to Ligand shareholders. Ligand … average number of common shares - diluted 16,733 … average number of common shares - diluted 17,421 … contingent consideration related to Pfenex, Icagen, Crystal, CyDex and Metabasis …

  • Ligand Reports Fourth Quarter and Full Year 2021 Financial Results 17 Feb 2022 21:01 GMT

    … eventual distribution of OmniAb shares to Ligand shareholders. … weighted average number of common shares - diluted   16,733   … 17,246       16,185   Add: shares excluded due to anti-dilutive … consideration related to Pfenex, Icagen, Crystal, CyDex and …

  • Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II 23 Mar 2022 20:17 GMT

    … to elect redemption of their shares. Avista has agreed to … received in lieu of fractional shares. Upon the closing of … candidates, as well as the Icagen ion channel technology. Ligand … statement on Form 10 registering shares of OmniAb common stock …

  • Ligand (LGND) Q4 Earnings Beat, OmniAb Spin 18 Feb 2022 17:46 GMT

    … .7 million. Ligand’s shares have declined 22.6% in … Initio antigen design technology, Icagen’s ion channel technology and … entity and distribution of the shares to existing Ligand shareholders. … with Glaxo leveraging its Icagen Ion Channel technology for …

Satisfied with the content?

Continue to create your account.